298 related articles for article (PubMed ID: 34864875)
21. Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2.
Nomburg J; Meyerson M; DeCaprio JA
Genome Med; 2020 Dec; 12(1):108. PubMed ID: 33256807
[TBL] [Abstract][Full Text] [Related]
22. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
[TBL] [Abstract][Full Text] [Related]
23. Application of omics technology to combat the COVID-19 pandemic.
Yang J; Yan Y; Zhong W
MedComm (2020); 2021 Sep; 2(3):381-401. PubMed ID: 34766152
[TBL] [Abstract][Full Text] [Related]
24. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
25. Unpacking Pandora From Its Box: Deciphering the Molecular Basis of the SARS-CoV-2 Coronavirus.
O'Leary VB; Dolly OJ; Höschl C; Černa M; Ovsepian SV
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396557
[TBL] [Abstract][Full Text] [Related]
26. ILRUN Downregulates ACE2 Expression and Blocks Infection of Human Cells by SARS-CoV-2.
Tribolet L; Alexander MR; Brice AM; van Vuren PJ; Rootes CL; Mara K; McDonald M; Bruce KL; Gough TJ; Shi S; Cowled C; Bean AGD; Stewart CR
J Virol; 2021 Jul; 95(15):e0032721. PubMed ID: 33963054
[TBL] [Abstract][Full Text] [Related]
27. Editorial: Revised World Health Organization (WHO) Terminology for Variants of Concern and Variants of Interest of SARS-CoV-2.
Parums V.
Med Sci Monit; 2021 Jun; 27():e933622. PubMed ID: 34149046
[TBL] [Abstract][Full Text] [Related]
28. COVID-19: Myths and Reality.
Kordyukova LV; Shanko AV
Biochemistry (Mosc); 2021 Jul; 86(7):800-817. PubMed ID: 34284707
[TBL] [Abstract][Full Text] [Related]
29. Calcium Signals during SARS-CoV-2 Infection: Assessing the Potential of Emerging Therapies.
Berlansky S; Sallinger M; Grabmayr H; Humer C; Bernhard A; Fahrner M; Frischauf I
Cells; 2022 Jan; 11(2):. PubMed ID: 35053369
[TBL] [Abstract][Full Text] [Related]
30. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
31. Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies.
Patrick MT; Zhang H; Wasikowski R; Prens EP; Weidinger S; Gudjonsson JE; Elder JT; He K; Tsoi LC
J Allergy Clin Immunol; 2021 Mar; 147(3):857-869.e7. PubMed ID: 33485957
[TBL] [Abstract][Full Text] [Related]
32. Biomedical omics: first insights of a new MSc degree of the University of Milan.
Alcalay M; Jereczek-Fossa BA; Pepa M; Volpe S; Zaffaroni M; Fiore F; Marvaso G; Pravettoni G; Curigliano G; Santaguida S; Pelicci PG
Tumori; 2022 Feb; 108(1):6-11. PubMed ID: 34585604
[TBL] [Abstract][Full Text] [Related]
33. Antiviral Strategies Against SARS-CoV-2: A Systems Biology Approach.
Prates ET; Garvin MR; Jones P; Miller JI; Sullivan KA; Cliff A; Gazolla JGFM; Shah MB; Walker AM; Lane M; Rentsch CT; Justice A; Pavicic M; Romero J; Jacobson D
Methods Mol Biol; 2022; 2452():317-351. PubMed ID: 35554915
[TBL] [Abstract][Full Text] [Related]
34. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
[TBL] [Abstract][Full Text] [Related]
35. The 2020 race towards SARS-CoV-2 specific vaccines.
Karpiński TM; Ożarowski M; Seremak-Mrozikiewicz A; Wolski H; Wlodkowic D
Theranostics; 2021; 11(4):1690-1702. PubMed ID: 33408775
[TBL] [Abstract][Full Text] [Related]
36. Electrochemical SARS-CoV-2 Sensing at Point-of-Care and Artificial Intelligence for Intelligent COVID-19 Management.
Kaushik AK; Dhau JS; Gohel H; Mishra YK; Kateb B; Kim NY; Goswami DY
ACS Appl Bio Mater; 2020 Nov; 3(11):7306-7325. PubMed ID: 35019473
[TBL] [Abstract][Full Text] [Related]
37. The Ineluctable Role of ACE-2 Receptors in SARS COV-2 Infection and Drug Repurposing as a Plausible SARS COV-2 Therapy: A Concise Treatise.
Joseph S; Nair B; Nath LR
Curr Mol Med; 2021; 21(10):888-913. PubMed ID: 33563197
[TBL] [Abstract][Full Text] [Related]
38. Analyzing the vast coronavirus literature with CoronaCentral.
Lever J; Altman RB
Proc Natl Acad Sci U S A; 2021 Jun; 118(23):. PubMed ID: 34016708
[TBL] [Abstract][Full Text] [Related]
39. Clinical and Genetic Characteristics of Coronaviruses with Particular Emphasis on SARS-CoV-2 Virus.
Iwanicka J; Iwanicki T; Kaczmarczyk M; Mazur W
Pol J Microbiol; 2022 Jun; 71(2):141-159. PubMed ID: 35716167
[TBL] [Abstract][Full Text] [Related]
40. Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives.
Mahmud I; Garrett TJ
J Am Soc Mass Spectrom; 2020 Oct; 31(10):2013-2024. PubMed ID: 32880453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
